Your email has been successfully added to our mailing list.

×
0 0 0 0.000433839479392693 -0.00412147505422989 0 0 -0.00216919739696315
Stock impact report

Sanofi finalizes Praluent® (alirocumab) restructuring with Regeneron

Sanofi - American Depositary Shares (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
Company Research Source: GlobeNewswire
Sanofi finalizes Praluent® (alirocumab) restructuring with Regeneron Paris – April 6, 2020 – Sanofi has finalized the planned restructuring related to Praluent® (alirocumab) with Regeneron Pharmaceuticals, Inc. Effective April 1, 2020, Sanofi will have sole responsibility for Praluent outside the U.S. Regeneron will have sole responsibility for Praluent in the U.S. The restructuring simplifies the antibody collaboration between the companies, increases efficiency, and streamlines operations for Praluent. Although each company will have responsibility for supplying Praluent in its respective territory, the companies have entered into agreements to support manufacturing needs in the near term. Sanofi announced its intent to restructure the antibody collaboration for Praluent and Kevzara® (sarilumab) in December 2019. Sanofi continues to work on assessing the restructuring related to Kevzara given the recently launched U.S. and global clinical programs evaluating Kevzara for patient Show less Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SNY alerts
Opt-in for
SNY alerts

from News Quantified
Opt-in for
SNY alerts

from News Quantified